PILA — Pila Pharma AB Income Statement
0.000.00%
Last trade - 00:00
- SEK102.31m
- SEK97.13m
- SEK1.46m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.346 | 0 | 0.719 | 1.88 | 1.46 |
Cost of Revenue | |||||
Gross Profit | -2.08 | -0.492 | 0.681 | 1.88 | -1.87 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 9.01 | 6.98 | 17.9 | 28.7 | 11.4 |
Operating Profit | -8.67 | -6.98 | -17.2 | -26.8 | -9.89 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -8.67 | -6.98 | -17.2 | -26.8 | -9.93 |
Provision for Income Taxes | |||||
Net Income After Taxes | -8.67 | -6.98 | -17.2 | -26.8 | -9.93 |
Net Income Before Extraordinary Items | |||||
Net Income | -8.67 | -6.98 | -17.2 | -26.8 | -9.93 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -8.67 | -6.98 | -17.2 | -26.8 | -9.93 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.286 | -0.205 | -0.713 | -0.515 | -0.305 |
Dividends per Share |